Fungal Spectrum and Susceptibility Against Nine Antifungal Agents in 525 Deep Fungal Infected Cases

References

• Bo L. 临床患者深部真菌感染菌群分布情况及耐药性分析 [Bacterial flora distribution and antibiotic resistance analysis for deep fungal infections of clinical patients]. China Modern Med. 2017;24(3):135–137. Chinese.
   Google Scholar
• Jenks JD, Cornely OA, Chen SC, Thompson GR, Hoenigl M. Breakthrough invasive fungal infections: who is at risk? Mycoses. 2020;63(10):1021–1032. doi:10.1111/myc.13148
   PubMed Web of Science ®Google Scholar
• Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367–1376. doi:10.1093/cid/ciz1008
   PubMed Web of Science ®Google Scholar
• Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165):165rv113. doi:10.1126/scitranslmed.3004404
   Web of Science ®Google Scholar
• Netea MG, Brown GD. Fungal infections: the next challenge. Curr Opin Microbiol. 2012;15(4):403–405. doi:10.1016/j.mib.2012.07.002
   PubMed Web of Science ®Google Scholar
• Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ. Invasive candidiasis. Nat Rev Dis Primers. 2018;4:18026. doi:10.1038/nrdp.2018.26
   PubMed Web of Science ®Google Scholar
• Rahi MS, Jindal V, Pednekar P, et al. Fungal infections in hematopoietic stem-cell transplant patients: a review of epidemiology, diagnosis, and management. Therap Adv Infect Dis. 2021;8:20499361211039050. doi:10.1177/20499361211039050
   Web of Science ®Google Scholar
• Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis. 2017;17(12):e383–e392. doi:10.1016/S1473-3099(17)30316-X
   PubMed Web of Science ®Google Scholar
• Revie NM, Iyer KR, Robbins N, Cowen LE. Antifungal drug resistance: evolution, mechanisms and impact. Curr Opin Microbiol. 2018;45:70–76. doi:10.1016/j.mib.2018.02.005
   PubMed Web of Science ®Google Scholar
• Mercer DK, O’Neil DA. Innate inspiration: antifungal peptides and other immunotherapeutics from the host immune response. Front Immunol. 2020;11:2177. doi:10.3389/fimmu.2020.02177
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN. Twenty years of the SENTRY antifungal surveillance program: results for candida species from 1997–2016. Open Forum Infect Dis. 2019;6(Suppl 1):S79–s94. doi:10.1093/ofid/ofy358
   PubMedGoogle Scholar
• Xiao M, Chen SC, Kong F, et al. Distribution and antifungal susceptibility of candida species causing candidemia in China: an update from the CHIF-NET study. J Infect Dis. 2020;221(Suppl 2):S139–s147. doi:10.1093/infdis/jiz573
   PubMedGoogle Scholar
• Bilal H, Shafiq M, Hou B, et al. Distribution and antifungal susceptibility pattern of Candida species from mainland China: a systematic analysis. Virulence. 2022;13(1):1573–1589. doi:10.1080/21505594.2022.2123325
   PubMed Web of Science ®Google Scholar
• Cai W, Lu C, Li X, et al. Epidemiology of superficial fungal infections in Guangdong, Southern China: a retrospective study from 2004 to 2014. Mycopathologia. 2016;181(5–6):387–395. doi:10.1007/s11046-016-9986-6
   PubMed Web of Science ®Google Scholar
• Wang X, Ding C, Xu Y, Yu H, Zhang S, Yang C. Analysis on the pathogenic fungi in patients with superficial mycosis in the Northeastern China during 10 years. Exp Ther Med. 2020;20(6):281. doi:10.3892/etm.2020.9411
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhang J, Li X, et al. Penicillium marneffei infection: an emerging disease in mainland China. Mycopathologia. 2013;175(1–2):57–67. doi:10.1007/s11046-012-9577-0
   PubMed Web of Science ®Google Scholar
• You Z, Yang X, Yu J, Zhang J, Ran Y. Chromoblastomycosis caused by Fonsecaea nubica: first report in Northern China and literature review. Mycopathologia. 2019;184(1):97–105. doi:10.1007/s11046-018-0307-0
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Bassetti M, Lass-Flörl C, Rácil Z, Richardson M, Rogers TR. Detection and investigation of invasive mould disease. J Antimicrob Chemother. 2011;66(Suppl 1):i15–24. doi:10.1093/jac/dkq438
   PubMedGoogle Scholar
• Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of Clinical Microbiology. ASM Press; 2015.
   Google Scholar
• Larone DH. Medically Important Fungi: A Guide to Identification. ASM Press; 2002.
   Google Scholar
• Institute CaLS. Performance Standards for Antifungal Susceptibility Testing of Yeasts. Institute CaLS; 2020.
   Google Scholar
• Clinical and Laboratory Standards Institute. Epidemiological Cutoff Values for Antifungal Susceptibility Testing. Clinical and Laboratory Standards Institute; 2020.
   Google Scholar
• Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–332. doi:10.1016/j.ajic.2008.03.002
   PubMed Web of Science ®Google Scholar
• Hao-min GD. Distribution and antimicrobial susceptibilities of invasive fungi isolated from sterile sites of inpatients in a hospital of Harbin. J Harbin Med Univ. 2017;24:187.
   Google Scholar
• Yang SP, Chen YY, Hsu HS, Wang FD, Chen LY, Fung CP. A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study. BMC Infect Dis. 2013;13:10. doi:10.1186/1471-2334-13-10
   PubMed Web of Science ®Google Scholar
• Scott LJ, Simpson D. Voriconazole: a review of its use in the management of invasive fungal infections. Drugs. 2007;67(2):269–298. doi:10.2165/00003495-200767020-00009
   PubMed Web of Science ®Google Scholar
• Ruiz-Ruigómez M, Dueñas C, Hernandez C, et al. Clinical predictors of candidemia in medical non-neutropenic, non-ICU patients. The CaMed score. Int J Clin Pract. 2018;72(12):e13275. doi:10.1111/ijcp.13275
   PubMed Web of Science ®Google Scholar
• Lamoth F, Lockhart SR, Berkow EL, Calandra T. Changes in the epidemiological landscape of invasive candidiasis. J Antimicrob Chemother. 2018;73(suppl_1):i4–i13. doi:10.1093/jac/dkx444
   PubMed Web of Science ®Google Scholar
• Chen M, Xu Y, Hong N, et al. Epidemiology of fungal infections in China. Front Med. 2018;12(1):58–75. doi:10.1007/s11684-017-0601-0
   PubMed Web of Science ®Google Scholar
• Xiao M, Sun ZY, Kang M, et al. Five-year national surveillance of invasive candidiasis: species distribution and azole susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study. J Clin Microbiol. 2018;56(7). doi:10.1128/JCM.00577-18
   Web of Science ®Google Scholar
• Vasilyeva NV, Raush ER, Rudneva MV, et al. Etiology of invasive candidosis agents in Russia: a multicenter epidemiological survey. Front Med. 2018;12(1):84–91. doi:10.1007/s11684-017-0612-x
   PubMed Web of Science ®Google Scholar
• Sasso M, Roger C, Sasso M, et al. Changes in the distribution of colonising and infecting Candida spp. isolates, antifungal drug consumption and susceptibility in a French intensive care unit: a 10-year study. Mycoses. 2017;60(12):770–780. doi:10.1111/myc.12661
   PubMed Web of Science ®Google Scholar
• Trouvé C, Blot S, Hayette MP, et al. Epidemiology and reporting of candidaemia in Belgium: a multi-centre study. Eur J Clin Microbiol Infect Dis. 2017;36(4):649–655. doi:10.1007/s10096-016-2841-3
   PubMed Web of Science ®Google Scholar
• Puig-Asensio M, Padilla B, Garnacho-Montero J, et al. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect. 2014;20(4):O245–O254. doi:10.1111/1469-0691.12380
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Gibbs DL, et al. Results from the ARTEMIS DISK global antifungal surveillance study, 1997 to 2007: a 10.5-year analysis of susceptibilities of candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol. 2010;48(4):1366–1377. doi:10.1128/JCM.02117-09
   PubMed Web of Science ®Google Scholar
• Tan BH, Chakrabarti A, Li RY, et al. Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study. Clin Microbiol Infect. 2015;21(10):946–953. doi:10.1016/j.cmi.2015.06.010
   PubMed Web of Science ®Google Scholar
• Eggimann P, Bille J, Marchetti O. Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care. 2011;1:37. doi:10.1186/2110-5820-1-37
   PubMed Web of Science ®Google Scholar
• Zeng B, Li J, Wang Y, et al. In vitro and in vivo effects of suloctidil on growth and biofilm formation of the opportunistic fungus Candida albicans. Oncotarget. 2017;8(41):69972–69982. doi:10.18632/oncotarget.19542
   PubMedGoogle Scholar
• Castanheira M, Messer SA, Rhomberg PR, Pfaller MA. Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013). Diagn Microbiol Infect Dis. 2016;85(2):200–204. doi:10.1016/j.diagmicrobio.2016.02.009
   PubMed Web of Science ®Google Scholar
• Suzuki K, Nakase K, Kyo T, et al. Fatal Trichosporon fungemia in patients with hematologic malignancies. Eur J Haematol. 2010;84(5):441–447. doi:10.1111/j.1600-0609.2010.01410.x
   PubMed Web of Science ®Google Scholar
• Li-na GU, Shu-ying YU, He WA, Ying-chun XU. Comparative evaluation of Sensititre YeastOne colorimetric panel with broth microdilution methods for antifungal susceptibility testing of Trichosporon asahii isolates. Chin J Mycol. 2017;12:198.
   Google Scholar
• Ying LI, Ying-chun XU. Evaluation of ITS, BenA and CaM in identification of clinical aspergillus. Chin J Mycol. 2017;12:74.
   Google Scholar
• Ala-Houhala M, Koukila-Kähkölä P, Antikainen J, Valve J, Kirveskari J, Anttila VJ. Clinical use of fungal PCR from deep tissue samples in the diagnosis of invasive fungal diseases: a retrospective observational study. Clin Microbiol Infect. 2018;24(3):301–305. doi:10.1016/j.cmi.2017.08.017
   PubMed Web of Science ®Google Scholar
• García-Salazar E, Acosta-Altamirano G, Betancourt-Cisneros P, et al. Detection and molecular identification of eight candida species in clinical samples by simplex PCR. Microorganisms. 2022;10(2):374. doi:10.3390/microorganisms10020374
   PubMed Web of Science ®Google Scholar
• Liu W, Li M, Xu Y, et al. Evaluation of the performance of a multiplex real-time PCR assay for the identification of aspergillus, Cryptococcus neoformans, and Pneumocystis jirovecii simultaneously from sputum in multicenter. Infect Drug Resist. 2022;15:6009–6017. doi:10.2147/IDR.S379043
   PubMed Web of Science ®Google Scholar